JW (Cayman) Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
JW (Cayman) Therapeutics has a total shareholder equity of CN¥1.7B and total debt of CN¥262.5M, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are CN¥2.1B and CN¥462.3M respectively.
Key information
15.6%
Debt to equity ratio
CN¥262.50m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.01b |
Equity | CN¥1.68b |
Total liabilities | CN¥462.26m |
Total assets | CN¥2.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JWCT.F's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥264.5M).
Long Term Liabilities: JWCT.F's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥197.8M).
Debt to Equity History and Analysis
Debt Level: JWCT.F has more cash than its total debt.
Reducing Debt: JWCT.F had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: JWCT.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: JWCT.F has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 13.6% each year.